INR 584.25
(2.63%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 985.34 Million INR | -4.47% |
2022 | 1.03 Billion INR | 29.4% |
2021 | 797.11 Million INR | 11.26% |
2020 | 716.42 Million INR | 38.38% |
2019 | 517.72 Million INR | 8.51% |
2018 | 477.12 Million INR | 12.81% |
2017 | 422.93 Million INR | 9.42% |
2016 | 386.51 Million INR | 12.57% |
2015 | 343.36 Million INR | 11.17% |
2014 | 308.86 Million INR | 3.36% |
2013 | 298.81 Million INR | 11.84% |
2012 | 267.17 Million INR | 15.41% |
2011 | 231.51 Million INR | -33.45% |
2010 | 347.89 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 294.53 Million INR | -46.05% |
2023 Q1 | 393.69 Million INR | 29.6% |
2023 Q2 | 440.66 Million INR | 11.93% |
2023 Q3 | 450.99 Million INR | 2.35% |
2023 Q4 | 235.49 Million INR | -47.78% |
2023 FY | 985.34 Million INR | -4.47% |
2022 Q4 | 303.78 Million INR | 25.87% |
2022 Q1 | 226.49 Million INR | 26.43% |
2022 Q2 | 259.81 Million INR | 14.71% |
2022 Q3 | 241.34 Million INR | -7.11% |
2022 FY | 1.03 Billion INR | 29.4% |
2021 FY | 797.11 Million INR | 11.26% |
2021 Q2 | 183.67 Million INR | -15.76% |
2021 Q4 | 179.15 Million INR | -17.15% |
2021 Q3 | 216.24 Million INR | 17.73% |
2021 Q1 | 218.04 Million INR | 52.55% |
2020 Q2 | 221.48 Million INR | 22.2% |
2020 FY | 716.42 Million INR | 38.38% |
2020 Q1 | 181.25 Million INR | 43.26% |
2020 Q4 | 142.93 Million INR | -16.29% |
2020 Q3 | 170.75 Million INR | -22.91% |
2019 Q1 | 127.34 Million INR | 22.31% |
2019 Q2 | 137.83 Million INR | 8.24% |
2019 FY | 517.72 Million INR | 8.51% |
2019 Q3 | 129.36 Million INR | -6.15% |
2019 Q4 | 126.51 Million INR | -2.2% |
2018 Q1 | 289.79 Million INR | 173.56% |
2018 Q4 | 104.11 Million INR | 0.0% |
2018 Q3 | 104.11 Million INR | -26.41% |
2018 Q2 | 141.47 Million INR | -51.18% |
2018 FY | 477.12 Million INR | 12.81% |
2017 Q1 | 96.09 Million INR | 7.64% |
2017 Q3 | 105.93 Million INR | 10.24% |
2017 Q2 | 96.09 Million INR | 0.0% |
2017 FY | 422.93 Million INR | 9.42% |
2017 Q4 | 105.93 Million INR | 0.0% |
2016 FY | 386.51 Million INR | 12.57% |
2016 Q4 | 89.27 Million INR | 0.0% |
2016 Q3 | 89.27 Million INR | -7.56% |
2016 Q2 | 96.58 Million INR | 0.0% |
2016 Q1 | 96.58 Million INR | 12.63% |
2015 Q1 | 96.15 Million INR | 0.0% |
2015 FY | 343.36 Million INR | 11.17% |
2015 Q3 | -833.23 Million INR | -966.54% |
2015 Q4 | 85.75 Million INR | 110.29% |
2015 Q2 | 96.15 Million INR | 0.0% |
2014 FY | 308.86 Million INR | 3.36% |
2013 FY | 298.81 Million INR | 11.84% |
2012 FY | 267.17 Million INR | 15.41% |
2011 FY | 231.51 Million INR | -33.45% |
2010 FY | 347.89 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aarti Drugs Limited | 1.16 Billion INR | 15.601% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 67.95% |
Albert David Limited | 1.02 Billion INR | 3.976% |
Alembic Limited | 872.45 Million INR | -12.939% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -14347.874% |
Hester Biosciences Limited | 908.84 Million INR | -8.418% |
Hikal Limited | 4.46 Billion INR | 77.926% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 53.613% |
Ind-Swift Limited | 946.56 Million INR | -4.097% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 55.232% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -138.914% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 8.271% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -507.383% |
Medico Remedies Limited | 59.67 Million INR | -1551.186% |
Morepen Laboratories Limited | 1.98 Billion INR | 50.422% |
Procter & Gamble Health Limited | 2.99 Billion INR | 67.105% |
RPG Life Sciences Limited | 1.63 Billion INR | 39.753% |
Sigachi Industries Limited | 579.88 Million INR | -69.92% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.361% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 29.758% |
Themis Medicare Limited | 1.12 Billion INR | 12.476% |
Unichem Laboratories Limited | 6.72 Billion INR | 85.35% |
Vaishali Pharma Limited | 84.02 Million INR | -1072.625% |
Venus Remedies Limited | 1.91 Billion INR | 48.58% |
Windlas Biotech Limited | 1 Billion INR | 2.103% |
ZIM Laboratories Limited | 1.01 Billion INR | 2.736% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 93.791% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -116.281% |
FDC Limited | 3.49 Billion INR | 71.845% |
Gufic Biosciences Limited | 1.18 Billion INR | 16.96% |
Jubilant Pharmova Limited | 14.45 Billion INR | 93.183% |
Nectar Lifesciences Limited | 932.7 Million INR | -5.644% |
Orchid Pharma Limited | 800.77 Million INR | -23.05% |
Alkem Laboratories Limited | 32.83 Billion INR | 96.999% |
Brooks Laboratories Limited | 51.18 Million INR | -1825.254% |
Eris Lifesciences Limited | 4.94 Billion INR | 80.066% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 91.535% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 61.421% |
Innova Captab Limited | 931.03 Million INR | -5.834% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -124.682% |
Wanbury Limited | 978.96 Million INR | -0.652% |
Lupin Limited | 125.09 Billion INR | 99.212% |
Sakar Healthcare Limited | 204.07 Million INR | -382.825% |
Aurobindo Pharma Limited | 55.65 Billion INR | 98.23% |
Divi's Laboratories Limited | 14.17 Billion INR | 93.046% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 60.164% |
Mankind Pharma Limited | 29.27 Billion INR | 96.634% |
Sequent Scientific Limited | 2.9 Billion INR | 66.044% |
Laurus Labs Limited | 11.9 Billion INR | 91.727% |
Neuland Laboratories Limited | 2.92 Billion INR | 66.368% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 93.339% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 97.901% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.213% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 52.945% |
Wockhardt Limited | 8.48 Billion INR | 88.38% |
Bal Pharma Limited | 555.62 Million INR | -77.34% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 98.972% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 30.571% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -1590.476% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 54.686% |
Shilpa Medicare Limited | 3.33 Billion INR | 70.447% |
Valiant Laboratories Limited | 138.02 Million INR | -613.868% |
Ajanta Pharma Limited | 30.46 Billion INR | 96.765% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -6832.702% |
Granules India Limited | 10.31 Billion INR | 90.445% |
Medicamen Biotech Limited | 335.16 Million INR | -193.986% |
Ipca Laboratories Limited | 18.98 Billion INR | 94.811% |
Syncom Formulations (India) Limited | 345.63 Million INR | -185.084% |
Piramal Enterprises Limited | 63.65 Billion INR | 98.452% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 95.4% |
NATCO Pharma Limited | 10.05 Billion INR | 90.203% |
Suven Life Sciences Limited | 109.75 Million INR | -797.809% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -2034.815% |
Strides Pharma Science Limited | 9.16 Billion INR | 89.246% |
Indoco Remedies Limited | 12.06 Billion INR | 91.83% |
Alpa Laboratories Limited | 127.38 Million INR | -673.548% |
Lasa Supergenerics Limited | 291.17 Million INR | -238.404% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 67.975% |